Birgit Keller

1.1k total citations
46 papers, 784 citations indexed

About

Birgit Keller is a scholar working on Pathology and Forensic Medicine, Ecology, Evolution, Behavior and Systematics and Orthopedics and Sports Medicine. According to data from OpenAlex, Birgit Keller has authored 46 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 9 papers in Ecology, Evolution, Behavior and Systematics and 6 papers in Orthopedics and Sports Medicine. Recurrent topics in Birgit Keller's work include Multiple Sclerosis Research Studies (16 papers), Fungal Plant Pathogen Control (9 papers) and Sports Performance and Training (5 papers). Birgit Keller is often cited by papers focused on Multiple Sclerosis Research Studies (16 papers), Fungal Plant Pathogen Control (9 papers) and Sports Performance and Training (5 papers). Birgit Keller collaborates with scholars based in Germany, United Kingdom and France. Birgit Keller's co-authors include Christian Visscher, George N. Henderson, A. Ahsan Ejaz, Duk‐Hee Kang, Takahiko Nakagawa, Jere D. Gallagher, Richard J. Johnson, Wei Mu, Yuri Y. Sautin and Thomas M. Beaver and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Applied and Environmental Microbiology.

In The Last Decade

Birgit Keller

42 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Keller Germany 15 155 113 109 102 96 46 784
José L. Olivares Spain 14 44 0.3× 14 0.1× 212 1.9× 22 0.2× 282 2.9× 22 901
Jonathan N. King Switzerland 28 23 0.1× 8 0.1× 127 1.2× 10 0.1× 93 1.0× 84 2.0k
Peter Rich Australia 19 91 0.6× 11 0.1× 121 1.1× 258 2.5× 3 0.0× 37 1.4k
Ko‐Huang Lue Taiwan 18 36 0.2× 5 0.0× 105 1.0× 11 0.1× 46 0.5× 47 896
Melissa K. Stuart United States 19 47 0.3× 14 0.1× 218 2.0× 96 0.9× 3 0.0× 49 1.1k
Yoshiko Nagano Japan 20 32 0.2× 6 0.1× 348 3.2× 40 0.4× 21 0.2× 38 1.4k
Laurie Gutmann United States 26 57 0.4× 5 0.0× 615 5.6× 59 0.6× 5 0.1× 85 2.2k
Albert C. England United States 16 57 0.4× 4 0.0× 175 1.6× 14 0.1× 89 0.9× 21 1.1k
Sonja Kukuljan Australia 15 154 1.0× 3 0.0× 223 2.0× 323 3.2× 9 0.1× 25 973
Jerzy Socha Poland 19 53 0.3× 3 0.0× 349 3.2× 11 0.1× 41 0.4× 70 1.3k

Countries citing papers authored by Birgit Keller

Since Specialization
Citations

This map shows the geographic impact of Birgit Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Keller more than expected).

Fields of papers citing papers by Birgit Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Keller. The network helps show where Birgit Keller may publish in the future.

Co-authorship network of co-authors of Birgit Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Keller. A scholar is included among the top collaborators of Birgit Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Keller. Birgit Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Stefano, Nicola De, Anat Achiron, Frederik Barkhof, et al.. (2023). Early onset of Action and Sustained Efficacy of MRI Outcomes during Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-Year MAGNIFY-MS Study. Multiple Sclerosis and Related Disorders. 71. 104322–104322. 3 indexed citations
3.
Stefano, Nicola De, Frederik Barkhof, Xavier Montalbán, et al.. (2022). Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 9(4). 22 indexed citations
4.
Brochet, Bruno, Raymond Hupperts, Dawn Langdon, et al.. (2021). Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis. Multiple Sclerosis and Related Disorders. 57. 103385–103385. 12 indexed citations
5.
Stefano, Nicola De, Frederik Barkhof, Xavier Montalbán, et al.. (2021). Reduction in CUA MRI Lesions in the First 6 Months after Cladribine Tablets Treatment for Highly Active Relapsing Multiple Sclerosis: MAGNIFY-MS Subgroup Analysis (1921). Neurology. 96(15_supplement). 1 indexed citations
7.
Stefano, Nicola De, Maria Pia Sormani, Gavin Giovannoni, et al.. (2021). Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies. Multiple Sclerosis Journal. 28(1). 111–120. 21 indexed citations
8.
Stefano, Nicola De, Anat Achiron, Frederik Barkhof, et al.. (2020). A 2-year Study to Evaluate the Onset of Action of Cladribine Tablets in Subjects with Highly Active Relapsing Multiple Sclerosis: Results from MAGNIFY-MS Baseline Analysis (1487). Neurology. 94(15_supplement). 2 indexed citations
9.
Jung, Klaus, Birgit Keller, Christoph A. Keller, et al.. (2019). Caecal Microbiota of Experimentally Campylobacter jejuni-Infected Chickens at Different Ages. Frontiers in Microbiology. 10. 2303–2303. 21 indexed citations
10.
Giovannoni, Gavin, Birgit Keller, & Dominic Jack. (2019). Durability of NEDA-3 status in patients with relapsing multiple sclerosis receiving cladribine tablets: CLARITY Extension (P3.2-100). Neurology. 92(15_supplement). 4 indexed citations
12.
Keller, Birgit, et al.. (2018). Resistance of Escherichia coli in Turkeys after Therapeutic or Environmental Exposition with Enrofloxacin Depending on Flooring. International Journal of Environmental Research and Public Health. 15(9). 1993–1993. 16 indexed citations
13.
14.
Keller, Birgit, et al.. (2013). Associação entre pressão arterial e estresse percebido em motoristas de ônibus. 2 indexed citations
15.
Keller, Birgit, et al.. (2010). Effect of Pre- and Postcompetition Emotional State on Salivary Cortisol in Top-Ranking Wrestlers. Perceptual and Motor Skills. 111(1). 81–86. 12 indexed citations
16.
Keller, Birgit, et al.. (2006). A influência do tempo de prática na motivação intrínseca de atletas de futebol masculino, da categoria juvenil de clubes profissionais. Lecturas: Educación física y deportes. 42. 1 indexed citations
17.
Keller, Birgit, et al.. (2006). A influência do treinamento mental (imagery) na performance de atletas de bodyboarding. Lecturas: Educación física y deportes. 29. 3 indexed citations
18.
Hoedemaker, Martina, et al.. (2006). Isolation von Hefen aus Milch von Kühen mit Mastitis und aus Tupferproben von der Melkanlage. 87. 1 indexed citations
19.
Okazaki, Victor Hugo Alves, et al.. (2005). A influência da posição de titular ou reserva na de auto-estima de atletas de futsal brasileiro. Lecturas: Educación física y deportes. 31. 1 indexed citations
20.
Chaitman, Bernard, Pierre Théroux, Jeffrey A. Gavard, et al.. (2001). Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release. Journal of the American College of Cardiology. 38(4). 1070–1077. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026